Journal of Clinical Medicine | Summary of the 2026 Academic Editorial Board Meeting at the EASD 2026, Held on 29 September 2026
The Academic Editorial Board Meeting of the Journal of Clinical Medicine (JCM, ISSN 2077-0383) was held on 29 September 2026 during the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026). Fourteen members took time out of their busy congress schedules to attend the meeting. We thank EASD for providing this platform for academic exchange. We also had a booth, where we met with our Guest Editors, Topical Advisory Panel Members, Editorial Board Members, and other interested scholars to exchange ideas and gather suggestions. The photo below shows our booth. We invite you to check our Announcements page for more events of interest. We hope to see you at our upcoming events.
Our booth #L.03 at the EASD 2026.
At the start of the Academic Editorial Board meeting, we presented JCM’s key performance metrics, including Impact Factor, CiteScore, distribution of authors, distribution of Editorial Board Members, Section performance data, 2025 citation performance, top Special Issues, top cited papers, and diverse marketing activities. Additional topics included the new MDPI editorial process, MDPI collaboration models with societies, an overview of the MDPI 2025 author and reviewer satisfaction survey, the MDPI research integrity team, and AI tools.
The following key topics were discussed at the meeting:
- The details of the editorial handling process were discussed;
- Members are concerned about excessive AI use in manuscript writing, and we share the journal’s relevant supervision and review standards;
- Members provided suggestions for improving the quality of submissions;
- Members expressed interest in more details on the travel grant;
- Members strongly supported the Academic Publishing Workshops (APWs), considering them particularly useful for strengthening relationships with universities and research communities while providing genuine educational value;
- Members suggested strengthening collaboration with societies. Society collaboration was highlighted as another potential route for increasing JCM’s academic visibility and strengthening its relationships with professional communities.
Attendee list (in no particular order):
- Dr. Luca Bertolaccini, European Institute of Oncology IRCCS, Italy;
- Dr. Adie Viljoen, Borthwick Research Centre, UK;
- Dr. Paola Ciriaco, IRCCS San Raffaele Scientific Institute, Italy;
- Dr. Enrico Brocco, Diabetic Foot Unit, Italy;
- Prof. Dr. Giorgio Costantino, Università degli Studi di Milano, Italy;
- Dr. Elena Criscuolo, Vita-Salute San Raffaele University, Italy;
- Dr. Alfredo Caturano, San Raffaele Roma University, Italy;
- Dr. Giuseppe Ristagno, 1 University of Milan, Italy, 2 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy;
- Dr. Paolo Arrigoni, ASST Pini-CTO, Italy;
- Dr. Salma Ayis, King's College London, UK;
- Dr. Luigi Gianturco, Commissione Medica AIA-FIGC, Italy;
- Prof. Dr. Patrizio Tatti, INI Institute, Rome, Italy;
- Dr. Ernesto Fasulo, 1 IRCCS San Raffaele Institute,Italy, 2 Vita-Salute San Raffaele University, Italy;
- Dr. Matteo Di Bari, Legnano Hospital, Italy.